GEM
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GEM, covering 2015-11-02 to 2023-03-24. Get the full timeline:
Most recent: Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]